12 employees
SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.
2016
$7.4M
from 1 investors over 1 rounds
SciRhom raised $7.4M on January 1, 2017
Investors: High-Tech Gründerfonds